ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egan, J.
Right arrow Articles by Woodcock, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egan, J.
Right arrow Articles by Woodcock, A.
Eur Respir J 1996; 9: 663-668
Copyright © ERS Journals Ltd 1996

Clinical Trial

Pulmonary diffusion impairment following heart transplantation: a prospective study

JJ Egan, L Lowe, N Yonan, AN Rahman, CA Campbell, AK Deiraniya, KB Carroll, and AA Woodcock

The aim of this prospective study was to confirm whether and when a fall in gas transfer occurs following heart transplantation (HT); and to examine the potential relationship between gas transfer and haemodynamic change, immuno-suppression and cytomegalovirus (CMV) infection. The lung physiology of 34 heart transplant recipients (HTR) and 14 control patients undergoing coronary artery bypass grafting (CABG) were studied. The absolute and standardized residual values of forced expiratory volume in one second (FEV1), forced vital capacity (FVC), residual volume (RV), forced residual volume (FRC), total lung capacity (TLC), transfer factor of the lungs for carbon monoxide (TL,CO) and carbon monoxide transfer coefficient (KCO) were measured before and at 30, 60, 90, 120 and 150 days after HT. These data were compared to haemodynamic status, graft rejection, cyclosporin levels and episodes of CMV infection. Lung function was studied in a group of patients before and 4 weeks after CABG. There was a significant fall in mean KCO after HT (pre-HT = 1.29 and post-HT = 1.06 mmol.min-1.kPa.L-1) but not after CABG (pre-CABG = 1.49, post-CABG = 1.5 mmol.min-1.kPa.L-1. No relationship was observed between gas transfer and CMV. At the latest stage following HT (150 days) there was a positive correlation between TL,CO (absolute value and standardized residual) and mean cyclosporin level (r = 0.48 and r = 0.44, respectively) and also between the absolute KCO and actual (r = 0.56) and mean (r = 0.55) cyclosporin levels. Following HT, there is an early fall in gas transfer, which is independent of the effects of surgery and bypass, implicating early immunosuppression (e.g. antithymocyte globulin/cyclosporin).


This article has been cited by other articles:


Home page
 ChestHome page
R. Ewert, C. Opitz, R. Wensel, M. Dandel, S. Mutze, and P. Reinke
Abnormalities of Pulmonary Diffusion Capacity in Long-term Survivors After Kidney Transplantation*
Chest, August 1, 2002; 122(2): 639 - 644.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Lenner, M. L. Padilla, A. S. Teirstein, A. Gass, and G. J. Schilero
Pulmonary Complications in Cardiac Transplant Recipients
Chest, August 1, 2001; 120(2): 508 - 513.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Ewert, R. Wensel, L. Bruch, S. Mutze, U. Bauer, M. Plauth, and F.-X. Kleber
Relationship Between Impaired Pulmonary Diffusion and Cardiopulmonary Exercise Capacity After Heart Transplantation
Chest, April 1, 2000; 117(4): 968 - 975.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Ewert, R. Wensel, M. Bettmann, S. Spiegelsberger, O. Grauhan, M. Hummel, and R. Hetzer
Ventilatory and Diffusion Abnormalities in Long-term Survivors After Orthotopic Heart Transplantation
Chest, May 1, 1999; 115(5): 1305 - 1311.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the European Respiratory Society.